News Focus
News Focus
Replies to #66615 on Biotech Values
icon url

julescat

09/25/08 8:16 PM

#66617 RE: DewDiligence #66615

Dew, do you think something like this (NUVO) is a possible outcome for GTCB? If so, how probable?

I would hope that even though GTCB trades well above cash on hand value that the assets don't sell for so little.
icon url

DewDiligence

09/26/08 12:20 AM

#66624 RE: DewDiligence #66615

NUVO – This bizarre slide is part of a presentation that NUVO and ARCA Biopharma (the acquiring company) gave to their respective employees today:



The full slide set is filed with the SEC at:
http://sec.gov/Archives/edgar/data/907654/000119312508201370/d425.htm
icon url

DewDiligence

01/28/09 5:01 AM

#72320 RE: DewDiligence #66615

Following its acquisition of NUVO in a reverse merger, ARCA Biopharma begins trading today on Nasdaq under the ticker symbol ABIO:

http://finance.yahoo.com/news/ARCA-biopharma-and-Nuvelo-bw-14174041.html